from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3280/accD5

LFCtreatmentdescriptionclass of inhibitor

-0.119

Amikacinug/mL Amikacintranslation

-0.137

Cap5-10ug/mL Capreomycintranslation

-0.610

Rox10-50 ug/mL Roxithromycintranslation

0.707

SM2-5 ug/mL Streptomycintranslation

0.063

Tet5-10 ug/mL Tetracyclinetranslation

-0.879

Rif0.2-5ug/mL Rifampicintranscription

-1.027

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.447

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.841

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.197

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.180

Clofazimine10-13 ug/mL Clofaziminerespiration

0.535

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.840

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.516

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.164

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.572

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.483

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.217

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.312

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.556

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.445

KCN5-20 ug/mL Potassium cyaniderespiration

0.914

NaN30.2-2 mM Sodium aziderespiration

1.026

Nigericin50 uM Nigericinrespiration

-1.390

TRC10-150 ug/mL Triclosanrespiration

-0.448

TRZ10-25 ug/mL Thioridazinerespiration

-1.805

Valinomycin0.5-10 uM Valinomycinrespiration

0.802

ZnSO42 mM ZnSO4respiration

0.439

menadione6-10 ug/mL Menadionerespiration

-0.186

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.787

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.001

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.167

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.536

NRP_1Non-replicating persistence stage 1dosRassociated

0.913

Amp0.2mg/mL AmpicillincellWall

0.901

Cephalexin20-100 ug/mL CephalexincellWall

0.755

Cerulenin0.32-5 ug/mL CerulenincellWall

0.842

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.670

EMB10-20 ug/mL EthambutolcellWall

0.952

Eta12-40 ug/mL EthionamidecellWall

0.538

INH0.2-0.4 ug/mL IsoniazidcellWall

0.928

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.699

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.787

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.011

BZA0.12 mg/mL BenzamidearomaticAmides

-1.056

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.964

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.106

H2O24 mM hydrogen peroxideDNAdamaging

0.881

Levo10 ug/mL LevofloxacinDNAdamaging

0.459

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.664

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.476

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.435

UVUV-irradiationDNAdamaging

-1.263

ARP41-4 ug/mL Antitubercular compound ARP4?

0.343

Antimycin12.5-50 ug/mL Antimycin A?

0.885

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.909

PA_110-50 ug/mL Antitubercular compound PA-1?

0.493

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.295

PA8240.2-2 ug/mL PA-824?

-0.313

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.001

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.865

Verapamil50 uM Verapamil?

0.868

mercaptoethanol2 mM 2-Mercaptoethanol?

0.994

methoxatin10-20 ug/mL Methoxatin?